• Fluconazole: A Benchmark for Resistance Models

  2026-08-11

  Fluconazole is more than a routine antifungal control: it is a mechanistic probe for ergosterol disruption, strain-specific susceptibility, and antifungal drug resistance research. This article translates comparative C. auris evidence into practical assay and model-selection decisions.

• Bestatin-Derived Inhibitors of IRAP and ERAP1

  2026-08-11

  The reference study develops α-hydroxy-β-amino acid derivatives of bestatin as selective inhibitors of oxytocinase-family M1 aminopeptidases. By combining stereoselective synthesis, enzyme assays, cellular evaluation, and X-ray crystallography, the authors identify a low-nanomolar IRAP inhibitor and show that GAMEN-loop interactions can strongly influence potency and selectivity.

• Carbapenemase Gene Transmission in CREC

  2026-08-10

  A 2025 BMC Microbiology study characterized carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong, China. Its combination of plasmid localization, conjugation, antimicrobial susceptibility testing, mobile-element analysis, and ERIC-PCR showed that blaNDM-1 was prevalent and readily transferable, while clonal and plasmid-associated dissemination both contributed to transmission risk.

• 5-Azacytidine: From Methylation to Viral Mimicry

  2026-08-09

  5-Azacytidine is more than a DNA demethylation agent: in the right epigenetic context, it can help expose endogenous viral signals to the immune system. This article translates recent PTEN-deficient glioblastoma findings into practical assay design, controls, and interpretation strategies.

• AG-126: ERK Signaling in Translational Neuroscience

  2026-08-08

  AG-126, also known as Tyrphostin AG-126, provides a pharmacological lens for studying ERK1/2 signaling in inflammatory and neurobiological systems. This thought-leadership article connects product-level evidence with findings that link Neuroligin 1 loss, D2-MSN hyperactivation, PKC overactivation, and repetitive behavior, while defining the limits of translating inflammatory-model data into circuit neuroscience.

• 3-Methyladenine for Autophagy Assays

  2026-08-07

  Use 3-Methyladenine as a time-sensitive class III PI3K perturbation to test whether autophagy initiation contributes to cardiac injury, cancer-cell survival, or migration phenotypes. This workflow emphasizes matched vehicle controls, flux-aware readouts, and careful interpretation of its persistent class I PI3K effects.

• Genetic Engineering Enhances Immunotherapy in Immune-Cold Tu

  2026-08-07

  He et al. (2025) present a tumor-targeted genetic engineering approach that orchestrates T cell immunity in 'immune-cold' solid tumors. Their dual-function plasmid vector significantly improves T cell infiltration and synergizes with established immunotherapies, holding promise for translational applications in solid tumor treatment.

• Anlotinib Hydrochloride: Shaping Translational Anti-Angiogen

  2026-08-06

  Explore how Anlotinib hydrochloride, a novel multi-target tyrosine kinase inhibitor, enables translational researchers to overcome hurdles in anti-angiogenic cancer research. This thought-leadership article integrates mechanistic insights, experimental best practices, and fresh clinical evidence—highlighting how APExBIO's Anlotinib hydrochloride advances the field beyond conventional tools.

• Sodium Ascorbate in Cancer Cell Assays: Reliable Solutions f

  2026-08-06

  This article provides scenario-driven guidance for biomedical researchers and lab technicians on using Sodium Ascorbate (SKU B1834) in cell viability, proliferation, and cytotoxicity workflows. With evidence-backed insights and practical Q&A, it demonstrates how APExBIO's Sodium Ascorbate ensures reproducibility and high performance in cancer research, especially for glioblastoma models.

• FTSJ3 Loss Drives R-Loop DNA Damage and Chemosensitivity in

  2026-08-05

  The referenced study uncovers FTSJ3 as a key regulator of R-loop homeostasis and genomic stability in lung cancer cells. Loss of FTSJ3 leads to excessive R-loop formation, increased DNA damage, and enhanced sensitivity to cisplatin, highlighting FTSJ3 as both a therapeutic target and a potential biomarker for chemotherapy responsiveness.

• Localized Muscle-Derived BDNF Regulates Early Neuromuscular

  2026-08-05

  This study uncovers the spatially restricted release of muscle-generated BDNF as a critical regulator in the initial formation of postsynaptic acetylcholine receptor (AChR) clusters at neuromuscular junctions (NMJs). By detailing the calcium-dependent mechanisms of BDNF trafficking and proteolytic processing, the research provides new insights into synapse assembly and potential experimental approaches for dissecting calcium signaling in synaptic development.

• Defined Culture Enhances Human Intestinal Organoid Modeling

  2026-08-04

  Capeling's dissertation establishes a reproducible protocol for generating human intestinal organoids (HIOs) from pluripotent stem cells using precisely defined culture environments, addressing key barriers in organoid research. The work enables more accurate studies of intestinal development and function, with broad implications for disease modeling and regenerative medicine.

• HDAC Inhibition Reverses EBV-Induced Plasticity in NPC

  2026-08-04

  The reference study elucidates how HDAC inhibition can reverse Epstein-Barr virus (EBV)-driven dedifferentiation in nasopharyngeal carcinoma (NPC) by restoring CEBPA expression and reducing cellular plasticity. This mechanistic insight provides an epigenetic framework for differentiation therapy in solid tumors, highlighting new strategies for targeting tumor adaptability and resistance.

• Ciclesonide: Applied Protocols for Asthma and ERAD Research

  2026-08-03

  Ciclesonide’s unique prodrug activation and potent glucocorticoid receptor binding enable precise modeling of respiratory inflammation and innovative protein degradation strategies. Explore step-by-step workflows and troubleshooting tips that unlock its translational value in both classic asthma research and next-generation ERAD-hijacking applications.

• HOBt (1-Hydroxybenzotriazole) in Advanced Peptide Synthesis

  2026-08-03

  HOBt (1-Hydroxybenzotriazole) enables bench scientists to achieve high-fidelity amide bond formation and minimize epimerization, especially in complex peptide and bioactive molecule workflows. This article covers real-world protocol upgrades, troubleshooting for challenging substrates, and insights from recent glucagon receptor antagonist synthesis.

15610 records 1/1041 page Next 12345 下5页 Last page